India · Delayed Price · Currency is INR Fermenta Biotech Company Description
Fermenta Biotech Limited, together with its subsidiaries, manufactures and markets chemicals, bulk drugs, enzymes in India, Europe, the United States, and internationally.
The company engages in the pharmaceutical formulations and environmental solutions; rents and sales properties; and sports and health awareness/education activities.
It offers various variants of vitamin D3, including crystalline oil, resin oil, cold water dispersible, and feed grade powder used in applications, such as pharmaceuticals, dietary and nutritional supplements, feed, injectables, soft gel capsules, premixes, food and beverage fortification, veterinary, feed and rodenticides; pharmaceutical ingredients comprising phenyramidol and silicon dry powder; nutritional premixes; and enzymes, used in oleochemicals, fine chemicals, active pharmaceutical ingredients, food and fragrances, leather, and biodiesel industry.
In addition, the company engages in the design, engineering, procurement, and construction of water and wastewater treatment plants; and offers operations and maintenance services, as well as property development business.
It serves manufacturers, and real estate industry. The company was formerly known as DIL Limited.
Fermenta Biotech Limited was incorporated in 1951 and is based in Thane, India. Fermenta Biotech Limited operates as a subsidiary of DVK Investments Private Limited.
| Country | India |
| Founded | 1951 |
| Industry | Pharmaceutical Preparations |
| Employees | 606 |
| CEO | Prashant Nagre |
Contact Details
Address: DIL Complex Thane, Maharashtra 400610 India | |
| Phone | 91 22 6798 0888 |
| Website | fermentabiotech.com |
Stock Details
| Ticker Symbol | 506414 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Prashant Nagre | Chief Executive Officer |
| Sumesh Gandhi | Chief Financial Officer |